Skip to main content
OpenTrials
Completed

NCT Number: NCT00148096

Mechanical Heat Recovery Ventilation on House Dust Mite Sensitive Asthma

Asthma has become increasingly common in the UK, demanding our consideration of the cause. Many patients with asthma are allergic to house dust mites, which thrive in modern housing. Improving ventilation in the home has been shown to reduce dust mite levels, by reducing humidity levels. It is hoped that, by removing the dust mites from homes, asthma may improve. In this study, 140 volunteers will have their carpets steam-cleaned and new allergy bedding provided, before a team of architects installs a ventilation system in the loft. Half of the units will be switched on at the beginning of the study. The other half will be switched on in 12 months time, but only the architects know which units are active. The medical team will compare the asthma, and measures of inflammation in the airways, over that year.

It is due for completion in April 2007.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Monklands General Hospital

North Lanarkshire, United Kingdom

About this study

The prevalence of asthma is rising sharply in the UK. The house dust mite is the most common trigger associated with asthma, thriving in the humid microclimate favoured by modern housing. Could this be redressed by investment in improved ventilation in local housing? In a pilot study in North Lanarkshire Council housing stock, we demonstrated that dust mite avoidance, in combination with installation of domestic mechanical heat recovery ventilation (MHRV), could inhibit the re-colonisation of house dust mites by reduction of indoor air humidity. In this second phase, a double blind randomized placebo- controlled trial will test the resultant effect on asthma. It will be complete in November 2006. 140 patients with asthma and house dust mite allergy are being recruited and all will have new bedding, mattress covers and carpets cleaned. All will have MHRV units installed in their home, but only half will be activated, before 12 months of environmental and clinical monitoring. The primary endpoint is morning peak flow rate. Secondary endpoints include symptom scores, spirometry, rates of exacerbations, quality-of-life, and economic evaluations. Demonstration that well ventilated, energy efficient dwellings improve the respiratory health of patients with allergic asthma could be of considerable importance in helping the NHS cope with the commonest chronic disease in Scotland.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • House dust mite sensitive
  • FEV1 greater than 50%
  • Symptomatic asthma or 12% reversibility on spirometry or 15%PEFR lability

Exclusion criteria

  • Multi-storey flat

Treatment and study plan

Mechanical Heat Recovery Ventilation

Device

De-humidification without loss of heat

Other names: Ventaxia

Primary outcomes

  1. morning Peak Flow

    Time frame: 1 year

Secondary outcomes

  1. symptom scores

    Time frame: 1 year

  2. exacerbation rates

    Time frame: 1 year

  3. quality of life

    Time frame: 1 year

  4. spirometry

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

University of Glasgow

Other

Collaborators

  • Chief Scientist Office of the Scottish Government
  • Communities Scotland
  • Energy Action Scotland
  • North Glasgow Primary Care Trust
  • North Lanarkshire Council
  • Scottish Power
  • South Lanarkshire Council
  • Vent-axia Ltd

Registry information

Official study title

Randomised Controlled Trial of Mechanical Heat Recovery Ventilation on Asthma Control of Patients Allergic to the House Dust Mite

Important dates

Study start
2003
Study completion
2007
First posted
Sep 7, 2005
Registry last updated
Dec 24, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.